Related Experiment Video
Updated: May 17, 2026
07:14
Phenotypic Characterization of Macrophages from Rat Kidney by Flow Cytometry
Published on: October 18, 2016
[Flow cytometry and acute renal rejection confirmed by histopathologic analysis]
Zoran Siftar1, Ivica Sokolić, Mirjana Mariana Kardum Paro
1Merkur University Hospital, Institute of Clinical Chemistry and Laboratory Medicine, Zagreb, Croatia. zoran.siftar@gmail.com
Summary
Immunologic monitoring post-transplantation is crucial for patient recovery. While antithymocyte globulin (ATG) therapy significantly alters lymphocyte counts, immune parameters did not reliably predict rejection episodes in this study.
Area of Science:
- Immunology
- Transplantation Medicine
- Clinical Pathology
Context:
- Solid organ and hematopoietic cell transplantation are standard treatments for end-stage diseases.
- Patients receive intensive immunosuppressive therapy to prevent rejection.
- Monitoring immune status is essential for managing transplant recipients.
Purpose:
- To evaluate the impact of immunosuppressive therapy on lymphocyte subsets post-transplantation.
- To determine if immune monitoring parameters can predict acute rejection episodes.
- To assess the role of antithymocyte globulin (ATG) in highly sensitized patients.
Summary:
- This study analyzed lymphocyte subsets in 54 transplant patients on quadruple immunosuppression.
- Antithymocyte globulin (ATG) therapy caused a rapid and significant decrease in lymphocyte counts.
- No significant differences in immune parameters were observed between patients with and without rejection episodes.
Impact:
- Immunologic monitoring is necessary for ATG therapy and patient recovery assessment.
- Current immune parameters may not reliably guide treatment decisions for preventing rejection.
- Further prospective studies are needed to validate immune monitoring for clinical decision-making.
